SAN

76.29

+3.8%↑

ARGX

727.8

+4.69%↑

SHL.DE

34.72

+2.94%↑

PHIA

22.35

+2.05%↑

SRT3

249.6

+2.46%↑

SAN

76.29

+3.8%↑

ARGX

727.8

+4.69%↑

SHL.DE

34.72

+2.94%↑

PHIA

22.35

+2.05%↑

SRT3

249.6

+2.46%↑

SAN

76.29

+3.8%↑

ARGX

727.8

+4.69%↑

SHL.DE

34.72

+2.94%↑

PHIA

22.35

+2.05%↑

SRT3

249.6

+2.46%↑

SAN

76.29

+3.8%↑

ARGX

727.8

+4.69%↑

SHL.DE

34.72

+2.94%↑

PHIA

22.35

+2.05%↑

SRT3

249.6

+2.46%↑

SAN

76.29

+3.8%↑

ARGX

727.8

+4.69%↑

SHL.DE

34.72

+2.94%↑

PHIA

22.35

+2.05%↑

SRT3

249.6

+2.46%↑

Home・Elenco Azioni・Fresenius SE & Co KGaA

Fresenius SE & Co KGaA

Chiusa

SettoreSettore sanitario

36.46 1.7

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

35.85

Massimo

36.76

Metriche Chiave
By Trading Economics
Entrata	31M 436M
Vendite	-337M 5.8B
P/E Media del settore	13.601 49.888
EPS	0.99
Rendimento da dividendi	2.96
Margine di Profitto	7.493
Dipendenti	177,783
EBITDA	58M 902M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+52.84% upside

Dividendi
By Dow Jones
Rendimento da dividendi Media del settore	2.96% 2.38%
Utili prossimi	5 ago 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-1.7B 21B
Apertura precedente	34.76
Chiusura precedente	36.46

Notizie sul Sentiment di mercato

By Acuity

60%

40%

281 / 344 Classifica in Healthcare

Fresenius SE & Co KGaA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

6 ago 2025, 10:45 UTC

Discorsi di Mercato

Utili

Fresenius Beats Subdued Expectations -- Market Talk

Confronto tra pari

Modifica del prezzo

Fresenius SE & Co KGaA Previsione

Obiettivo di Prezzo

By TipRanks

52.84% in crescita

Previsioni per 12 mesi

Media 54.96 EUR 52.84%

Alto 58 EUR

Basso 48 EUR

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Fresenius SE & Co KGaA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

10 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 10 che hanno fornito valutazioni azionarie a Fresenius SE & Co KGaA - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

281 / 344 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Fresenius SE & Co KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.